UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nomograms for preoperative prediction of axillary nodal status in breast cancer

British journal of surgery, 2017-10, Vol.104 (11), p.1494-1505

2017

Volltextzugriff (PDF)

Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer: A sub-study of RASTEN - A randomized trial with low molecular weight heparin

PloS one, 2018-11, Vol.13 (11), p.e0207387-e0207387

2018

Volltextzugriff (PDF)

Genomic profiling of malignant melanoma using tiling-resolution arrayCGH

Oncogene, 2007-07, Vol.26 (32), p.4738-4748

2007

Volltextzugriff (PDF)

Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer: the Danish cohort of BIG 1-98

Breast cancer research and treatment, 2017-11, Vol.166 (2), p.481-490

2017

Volltextzugriff (PDF)

A prospective, multicenter validation study of a prognostic index composed of S-phase fraction, progesterone receptor status, and tumour size predicts survival in node-negative breast cancer patients: NNBC, the node-negative breast cancer trial

Annals of oncology, 2013-09, Vol.24 (9), p.2284-2291

2013

Volltextzugriff (PDF)

Low-molecular-weight heparin adherence and effects on survival within a randomised phase III lung cancer trial (RASTEN)

European journal of cancer (1990), 2019-09, Vol.118, p.82-90

2019

Volltextzugriff (PDF)

AIB1 is a predictive factor for tamoxifen response in premenopausal women

Annals of oncology, 2010-02, Vol.21 (2), p.238-244

2010

Volltextzugriff (PDF)

Validation of the Skåne University Hospital nomogram for the preoperative prediction of a disease-free axilla in patients with breast cancer

BJS open, 2021-05, Vol.5 (3)

2021

Volltextzugriff (PDF)

Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer: the RASTEN trial

Annals of oncology, 2018-02, Vol.29 (2), p.398-404

2018

Volltextzugriff (PDF)

Adjuvant radiotherapy of women with breast cancer – Information, support and side-effects

European journal of oncology nursing : the official journal of European Oncology Nursing Society, 2010-04, Vol.14 (2), p.147-153

2010

Volltextzugriff (PDF)

Cosmetic Outcomes and Symmetry Comparison in Patients Undergoing Bilateral Therapeutic Mammoplasty for Breast Cancer

World journal of surgery, 2021-05, Vol.45 (5), p.1433-1441

2021

Volltextzugriff (PDF)

A prospective cohort study identifying radiologic and tumor related factors of importance for breast conserving surgery after neoadjuvant chemotherapy

European journal of surgical oncology, 2023-07, Vol.49 (7), p.1189-1195

2023

Volltextzugriff (PDF)

St Gallen 2019 guidelines understage the axilla in lobular breast cancer: a population-based study

British journal of surgery, 2021-12, Vol.108 (12), p.1465-1473

2021

Volltextzugriff (PDF)

Towards optimised information about clinical trials; identification and validation of key issues in collaboration with cancer patient advocates

European journal of cancer care, 2011-07, Vol.20 (4), p.445-454

2011

Volltextzugriff (PDF)

S-Phase Fraction and Urokinase Plasminogen Activator Are Better Markers for Distant Recurrences Than Nottingham Prognostic Index and Histologic Grade in a Prospective Study of Premenopausal Lymph Node–Negative Breast Cancer

Journal of clinical oncology, 2001-04, Vol.19 (7), p.2010-2019

2001

Volltextzugriff (PDF)

Association between preoperative plasma levels of tissue inhibitor of metalloproteinases 1 and rectal cancer patient survival: a validation study

European journal of cancer (1990), 2004-01, Vol.40 (1), p.64-72

2004

Volltextzugriff (PDF)

Effects of adjuvant tamoxifen over three decades on breast cancer–free and distant recurrence–free interval among premenopausal women with oestrogen receptor–positive breast cancer randomised in the Swedish SBII:2pre trial

European journal of cancer (1990), 2019-03, Vol.110, p.53-61

2019

Volltextzugriff (PDF)

St Gallen molecular subtypes in screening-detected and symptomatic breast cancer in a prospective cohort with long-term follow-up

British journal of surgery, 2016-04, Vol.103 (5), p.513-523

2016

Volltextzugriff (PDF)

Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes

Cancer, 1998-07, Vol.83 (2), p.310-319

1998

Volltextzugriff (PDF)

Validated prediction model for positive resection margins in breast-conserving surgery based exclusively on preoperative data

BJS open, 2021-10, Vol.5 (5)

2021

Volltextzugriff (PDF)

Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer

European journal of cancer (1990), 2001-12, Vol.37 (18), p.2339-2348

2001

Volltextzugriff (PDF)

Urokinase plasminogen activator, a strong independent prognostic factor in breast cancer, analysed in steroid receptor cytosols with a luminometric immunoassay

European journal of cancer (1990), 1996-05, Vol.32 (5), p.793-801

1996

Volltextzugriff (PDF)

DNA‐synthesizing enzymes in breast cancer (thymidine kinase, thymidylate synthase and thymidylate kinase): Association with flow cytometric s‐phase fraction and relative prognostic importance in node‐negative premenopausal patients

International journal of cancer, 2001-01, Vol.95 (1), p.56-61

2001

Volltextzugriff (PDF)

Prognostic importance of the soluble plasminogen activator receptor, suPAR, in plasma from rectal cancer patients

European journal of cancer (1990), 2001-03, Vol.37 (4), p.486-491

2001

Volltextzugriff (PDF)

Haplotype analysis and age estimation of the 113insR CDKN2A founder mutation in Swedish melanoma families

Genes chromosomes & cancer, 2001-06, Vol.31 (2), p.107-116

2001

Volltextzugriff (PDF)

1 – 25 von 120

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(113)
Mit Volltextzugriff
(117)

Publikationsform

Artikel
(111)
Tagungsberichte
(9)

Sprache

Englisch
(119)
Schwedisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nomograms for preoperative prediction of axillary nodal status in breast cancer

Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer: A sub-study of RASTEN - A randomized trial with low molecular weight heparin

Genomic profiling of malignant melanoma using tiling-resolution arrayCGH

Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer: the Danish cohort of BIG 1-98

A prospective, multicenter validation study of a prognostic index composed of S-phase fraction, progesterone receptor status, and tumour size predicts survival in node-negative breast cancer patients: NNBC, the node-negative breast cancer trial

Low-molecular-weight heparin adherence and effects on survival within a randomised phase III lung cancer trial (RASTEN)

AIB1 is a predictive factor for tamoxifen response in premenopausal women

Validation of the Skåne University Hospital nomogram for the preoperative prediction of a disease-free axilla in patients with breast cancer

Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer: the RASTEN trial

Adjuvant radiotherapy of women with breast cancer – Information, support and side-effects

Cosmetic Outcomes and Symmetry Comparison in Patients Undergoing Bilateral Therapeutic Mammoplasty for Breast Cancer

A prospective cohort study identifying radiologic and tumor related factors of importance for breast conserving surgery after neoadjuvant chemotherapy

St Gallen 2019 guidelines understage the axilla in lobular breast cancer: a population-based study

Towards optimised information about clinical trials; identification and validation of key issues in collaboration with cancer patient advocates

S-Phase Fraction and Urokinase Plasminogen Activator Are Better Markers for Distant Recurrences Than Nottingham Prognostic Index and Histologic Grade in a Prospective Study of Premenopausal Lymph Node–Negative Breast Cancer

Association between preoperative plasma levels of tissue inhibitor of metalloproteinases 1 and rectal cancer patient survival: a validation study

Effects of adjuvant tamoxifen over three decades on breast cancer–free and distant recurrence–free interval among premenopausal women with oestrogen receptor–positive breast cancer randomised in the Swedish SBII:2pre trial

St Gallen molecular subtypes in screening-detected and symptomatic breast cancer in a prospective cohort with long-term follow-up

Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes

Validated prediction model for positive resection margins in breast-conserving surgery based exclusively on preoperative data

Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer

Urokinase plasminogen activator, a strong independent prognostic factor in breast cancer, analysed in steroid receptor cytosols with a luminometric immunoassay

DNA‐synthesizing enzymes in breast cancer (thymidine kinase, thymidylate synthase and thymidylate kinase): Association with flow cytometric s‐phase fraction and relative prognostic importance in node‐negative premenopausal patients

Prognostic importance of the soluble plasminogen activator receptor, suPAR, in plasma from rectal cancer patients

Haplotype analysis and age estimation of the 113insR CDKN2A founder mutation in Swedish melanoma families

Suchergebnisse filtern